Lung Cancer

You are here

Lung Cancer

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

ASCO 2018 - Will Taking Mod to High Dose Steroids Affect Lung Cancer Patients on Immunotherapy?
Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Pain Medication, Immunotherapies
ASCO 2018 Roundtable - Checkmate 227 - Combinations of Nivolumab and Ipilimumab, or Nivolumab and and Chemo
Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Chemotherapy, Immunotherapies
,
,
,
,
OncTalk 2018 - Local Therapies for Metastatic Lung Cancer - Who, What, Why, When and How?
On Saturday, November 10, 2018, GRACE partnered with Swedish Cancer Institute to present a discussion on Local Therapies for Metastatic Lung Cancer...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Scans - PET-CT, etc., Radiation Therapy, Surgical, Chemotherapy, Non Small Cell Lung Cancer, Immunotherapies
GRACE & Living Yoga Therapy Present: Living Through Cancer and Managing Anger
GRACE is excited to bring to you more in our new series on surviving with cancer GRACE is excited to bring to you more in our series on surviving...
Cancer Journey:
Just Diagnosed, In Treatment, In Remission, Survivorship
Cancer Type:
Lung Cancer, Blood Cancers, Head and Neck Cancer, Other
Disease Learning:
GRACE & Living Yoga Therapy Present: Power Yoga to Build Resiliency
GRACE is excited to bring to you more in our new series on surviving with cancer GRACE is excited to bring to you more in our series on surviving...
Cancer Journey:
Just Diagnosed, In Treatment, In Remission, Survivorship
Cancer Type:
Lung Cancer, Blood Cancers, Head and Neck Cancer, Other
Disease Learning:

Articles

Retrospective Data and Real World Evidence: The Poor Stepchild of Clinical Trials?
Many physicians worship evidence-based medicine, which is generally a very good practice that ensures that medical practice isn’t dictated by our...
Cancer Journey:
Cancer Type:
Lung Cancer, Blood Cancers, Head and Neck Cancer, Other
Disease Learning:
Clinical Trials
Why I Don't Favor a Front-Loaded Approach for Most Advanced NSCLC Patients
To many, the recent FDA approval of a combination of chemotherapy and concurrent immunotherapy for the vast majority of patients with advanced (metastatic) non-squamous non-small cell lung cancer (NSCLC) probably seems like a great idea.
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Why Carboplatin, Pemetrexed and Pembrolizumab Have Become My New Go-to Regimen for First-Line Non-Squamous NSCLC Treatment
Dr. Jonathan Goldman joins GRACE to explain why carboplatin, pemetrexed and pembrolizumab has become his new go-to regimen for first-line non-squamous NSCLC treatment.
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
My Top 10 ASCO 2017 Lung Cancer Presentations
Over the next few days, about 30,000 oncologists and other cancer care professionals, along with a growing number of patient advocates, are...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Non Small Cell Lung Cancer, Small Cell Lung Cancer
New FDA Approval for Zykadia (ceritinib) for ALK-Positive NSCLC: Why I Think It's a Poor Choice for Initial Treatment
The FDA just approved a new therapy for the approximately 4% of patients with NSCLC who have the molecular marker known as an ALK rearrangement. The...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapy, Targeted Therapies – ALK

Community Forum

Non-Small Cell Lung Cancer Patients and Caregivers -- opportunity to participate in a study for 'Rare Patient Voice'
Hi All - I was approached by a WhatNext Group partnered with Rare Patient Voice, with the opportunity to participate in a study specifically for Non-...
Cancer Journey:
Survivorship
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, General Lung Cancer
Evaluating Sclc using CT no Contrast
Hi, What is the view on using CT without contrast for detecting small cell? In my initial investigation they used contrast but post treatment they...
Cancer Journey:
In Remission
Cancer Type:
Lung Cancer
Disease Learning:
Local therapies for metastatic NSCLC while on Osmirtinib
Hi. I listened to a panel discussion on Saturday Nov 10, led by Dr Jack West, on local therapies for oligo-progression or oligo-metastatic disease...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Average To Progression after Chemo/Rad. ?
What is the average time to progression after chemo/radiation for Stage 3 NSCLC if the tumor shrank but was still not a candidate for surgical...
Cancer Journey:
In Remission
Cancer Type:
Lung Cancer
Disease Learning:
Adrenal metastasis from NSCLC
Greetings all, I'm a medical doctor from Vietnam. I want to discuss to you about my patient. He is 58 years old, he is hospitalize with chronic...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, Chemo Medication, Chemotherapy, First-line treatment